Brazil health regulator Anvisa allows Chinese COVID-19 vaccine trial

iStock [illustration]

Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.

Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.

According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.

It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.

More from International

Coming Up on Dubai Eye

  • Dubai Eye on One

    7:00am - 12:00pm

    Keeping you updated, this is The Business Breakfast, setting your agenda for the day. You're listening to Dubai Eye, live on Dubai One

  • The Sounds of Summer with Mark Lloyd

    12:00pm - 2:00pm

    Mark Lloyd wants to help you navigate places to explore across the UAE. There will also be LIVE interviews and features, continuing the conversation on the day’s biggest news stories. Plus we’ll be playing the biggest summer tracks.

On Dubai Eye

Business Breakfast